Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs THC✓SelectedUSD · THCMRNA vs THC performance historyLatest closeAs of-4.84%11/18
Stock and ETF performance explorer

MRNA vs THC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+713.9%
THC return
+40.9%
Excess return
+673.0%
Maximum drawdown
-34.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioTHCExcessAlpha
1D-4.8%-3.8%-1.0%-4.6%
7D-20.9%-7.4%-13.5%-20.5%
30D-13.3%+1.9%-15.1%-13.1%
3M+212.6%+0.4%+212.1%+213.4%
6M+309.0%+41.0%+268.0%+301.7%
YTD+567.3%+36.5%+530.8%+570.3%
All+713.9%+40.9%+673.0%+711.8%

Cumulative growth

Daily Returns

Daily percentage return beside THC.

Daily Out/Under-Performance

Portfolio return minus THC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling